title: Colloidal bismuth subcitrate inhibits peptic degradation of gastric mucus and epidermal growth factor in vitro.
abstract: The effect of an antiulcer drug, colloidal bismuth subcitrate (De-Nol), on the proteolytic activity of pepsin toward gastric mucus and salivary epidermal growth factor was investigated. Samples of pig gastric mucus and mouse epidermal growth factor were incubated with pepsin in the absence and in the presence of De-Nol, and the released alpha-amino acid residues were quantified. Results of analysis revealed that, in the absence of De-Nol, the apparent Km value of pepsin toward gastric mucus was 1.4 g/L and that towards epidermal growth factor 120 microM. Introduction of De-Nol to the incubation mixtures led, in both cases, to reduction of the rates of proteolysis. With gastric mucus, the rate of proteolysis inhibition was proportional to the De-Nol concentration up to 1 x 10(-2) g/L, at which point a 54% reduction in mucus proteolysis occurred, whereas, with epidermal growth factor, this concentration of De-Nol caused nearly 52% inhibition in the rate of proteolysis. The apparent Ki value for peptic degradation of gastric mucus in the presence of De-Nol was 2.1 x 10(-4) g/L and that for peptic degradation of epidermal growth factor 1.8 x 10(-2) g/L. The results suggest that among the beneficial effects of colloidal bismuth subcitrate on ulcer healing is its ability to interfere with peptic digestion of the protective gastric mucus coat and of such important bioactive protein as epidermal growth factor.
authors.affiliation: Research Center, New Jersey Dental School, University of Medicine and Dentistry of New Jersey, Newark.
authors.forename: B L
authors.initials: BL
authors.lastname: Slomiany
authors.forename: H
authors.initials: H
authors.lastname: Nishikawa
authors.forename: J
authors.initials: J
authors.lastname: Bilski
authors.forename: A
authors.initials: A
authors.lastname: Slomiany
mesh_terms: D000818:Animals; D000897:Anti-Ulcer Agents / Q000494:pharmacology*; D001729:Bismuth / Q000494:pharmacology; D004815:Epidermal Growth Factor / Q000378:metabolism*; D066298:In Vitro Techniques; D051379:Mice; D009093:Mucus / Q000378:metabolism*; D009942:Organometallic Compounds / Q000494:pharmacology*; D010434:Pepsin A / Q000037:antagonists & inhibitors*; D013552:Swine
chemical_list: D000897:Anti-Ulcer Agents; D009942:Organometallic Compounds; D004815:Epidermal Growth Factor; D010434:Pepsin A; C002791:bismuth tripotassium dicitrate; D001729:Bismuth